Literature DB >> 34792713

Systolic Dysfunction of the Heart in Type 1 Diabetes Mellitus.

V L Lakomkin1, A A Abramov2, E V Lukoshkova2, A V Prosvirnin2, V I Kapelko2.   

Abstract

Impaired insulin synthesis is accompanied by hyperglycemia and the development of diabetic cardiomyopathy. Echocardiography and left-ventricular catheterization were employed for studying the contractile function of the left ventricle in 2 weeks after administration of streptozotocin (60 mg/kg). The results obtained by both methods were similar and indicated the development of systolic dysfunction with a 27% decrease in cardiac output. The invasive study showed that the maximum rate of left-ventricular pressure development, the contractility index, and systolic left-ventricular pressure were within the normal range, but the peak ejection rate was reduced by 28%. BP was normal, but the vascular stiffness index was increased by about 1.5 times and inversely correlated with the peak ejection rate (r=-0.69). The results showed that systolic dysfunction in type 1 diabetes model was due to reduced ejection from the left ventricle at normal rate of left-ventricular pressure development.
© 2021. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  contractility; diabetes mellitus; ejection fraction; heart; pressure-volume

Mesh:

Substances:

Year:  2021        PMID: 34792713     DOI: 10.1007/s10517-021-05321-1

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  15 in total

Review 1.  Role of changes in cardiac metabolism in development of diabetic cardiomyopathy.

Authors:  Ding An; Brian Rodrigues
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-06-02       Impact factor: 4.733

Review 2.  Diabetic Cardiomyopathy.

Authors:  Wolfgang H Dillmann
Journal:  Circ Res       Date:  2019-04-12       Impact factor: 17.367

3.  Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat.

Authors:  Antonio Ceriello; Lisa Quagliaro; Michele D'Amico; Clara Di Filippo; Raffaele Marfella; Francesco Nappo; Liberato Berrino; Francesco Rossi; Dario Giugliano
Journal:  Diabetes       Date:  2002-04       Impact factor: 9.461

4.  Abnormal cardiac function in the streptozotocin-induced non-insulin-dependent diabetic rat: noninvasive assessment with doppler echocardiography and contribution of the nitric oxide pathway.

Authors:  I I Joffe; K E Travers; C L Perreault-Micale; T Hampton; S E Katz; J P Morgan; P S Douglas
Journal:  J Am Coll Cardiol       Date:  1999-12       Impact factor: 24.094

5.  Abnormal cardiac function in the streptozotocin-diabetic rat. Changes in active and passive properties of the left ventricle.

Authors:  S E Litwin; T E Raya; P G Anderson; S Daugherty; S Goldman
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

6.  [Pressure and Volume Characteristics of the Left Ventriclе in Its Diastolic and Systolic Dysfunction].

Authors:  A A Abramov; V L Lakomkin; A V Prosvirnin; V I Kapelko
Journal:  Kardiologiia       Date:  2019-04-17       Impact factor: 0.395

Review 7.  Left ventricular diastolic dysfunction: an early sign of diabetic cardiomyopathy?

Authors:  S Cosson; J P Kevorkian
Journal:  Diabetes Metab       Date:  2003-11       Impact factor: 6.041

8.  Altered myocardial mechanics in diabetic rats.

Authors:  F S Fein; L B Kornstein; J E Strobeck; J M Capasso; E H Sonnenblick
Journal:  Circ Res       Date:  1980-12       Impact factor: 17.367

9.  Myocardial performance in conscious streptozotocin diabetic rats.

Authors:  Giulianna R Borges; Mauro de Oliveira; Helio C Salgado; Rubens Fazan
Journal:  Cardiovasc Diabetol       Date:  2006-12-04       Impact factor: 9.951

Review 10.  Type 1 diabetes and cardiovascular disease.

Authors:  Oliver Schnell; Francesco Cappuccio; Stefano Genovese; Eberhard Standl; Paul Valensi; Antonio Ceriello
Journal:  Cardiovasc Diabetol       Date:  2013-10-28       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.